1998
DOI: 10.1002/j.2048-7940.1998.tb01766.x
|View full text |Cite
|
Sign up to set email alerts
|

Use of the Apathy Evaluation Scale as a Measure of Motivation in Elderly People

Abstract: Motivation plays an important part in an elderly individual's ability to recover from a disabling event. On the other hand, apathy is a lack of motivation. The Apathy Evaluation Scale (AES) is an 18‐item instrument that rates a person's thoughts, actions, and emotions over the previous 4 weeks. The purpose of this study was to use the AES with 102 patients in a geriatric rehabilitation program to determine if it predicted improved function after rehabilitation. In addition, a short 7‐item version of the AES wa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
58
0
2

Year Published

2002
2002
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 72 publications
(62 citation statements)
references
References 31 publications
2
58
0
2
Order By: Relevance
“…Statistically significant and fair to high correlation between the AES-I and AES-C and other measures of apathy (e.g., NPI-apathy subscale (57), the Lille Apathy Rating Scale [LARS] (59;60), and the PANSS-negative symptom (NS) subscale, particularly the emotional withdrawal item (58) indicated fair to good convergent validity. Understandably, the AES-I was also correlated highly with scores on the 7-item Apathy Scale (AS-7) (61) that was validated in a geriatric rehabilitation inpatients and the 10-item Apathy Scale (AS-10) (62) that was validated in geriatric nursing home residents given seven or more common items. Good discriminant validity was also demonstrated for the AES-I and AES-C as evident by low correlations with depression and anxiety measures (46;47;57) and the positive factor of the PANSS (58).…”
Section: Apathy Evaluation Scale (Aes)mentioning
confidence: 96%
See 2 more Smart Citations
“…Statistically significant and fair to high correlation between the AES-I and AES-C and other measures of apathy (e.g., NPI-apathy subscale (57), the Lille Apathy Rating Scale [LARS] (59;60), and the PANSS-negative symptom (NS) subscale, particularly the emotional withdrawal item (58) indicated fair to good convergent validity. Understandably, the AES-I was also correlated highly with scores on the 7-item Apathy Scale (AS-7) (61) that was validated in a geriatric rehabilitation inpatients and the 10-item Apathy Scale (AS-10) (62) that was validated in geriatric nursing home residents given seven or more common items. Good discriminant validity was also demonstrated for the AES-I and AES-C as evident by low correlations with depression and anxiety measures (46;47;57) and the positive factor of the PANSS (58).…”
Section: Apathy Evaluation Scale (Aes)mentioning
confidence: 96%
“…Resnick et al’s AS-7 (61) and Leuken et al’s AS-10 (62) represent truncated versions of the AES that result from removal of some items that were determined to be redundant (53;61) or inappropriate for the group being assessed (62). Judgment of redundancy was based on factor analyses (53;61) whereas inappropriateness was judged by experts with special knowledge of the population being assessed (61;62). The intent of these abridged versions of the AES was to better capture apathy in the respective populations with reliable and valid measures while possibly requiring less time although not explicitly stated.…”
Section: Apathy Evaluation Scale (Aes)mentioning
confidence: 99%
See 1 more Smart Citation
“…It contributes significantly to carer burden 9 10 and has negative implications for treatment and long term outcome. [11][12][13] In Parkinson's disease, there is no evidence that the symptoms of apathy are improved by levodopa treatment, although there are early indications that the dopamine D3 receptor agonist, pramipexole, 14 15 and cholinesterase inhibitors may be of some value. 16 17 Current estimates of the prevalence of apathy in Parkinson's disease vary between 16.5% 6 and 42%, 2 depending upon the instrument used for assessment and on the samples examined.…”
mentioning
confidence: 99%
“…Impairments in cognition [1] and motivation [2] are common after stroke and predict poor functional recovery [3,4,5]. We propose that pharmacological agents that enhance cognition and/or diminish apathy may, when combined with traditional rehabilitative efforts, lead to improved functional recovery.…”
Section: Introductionmentioning
confidence: 99%